These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Unspecific, active BCG vaccination therapy in melanoma using a modified scarification procedure]. Wolf M; Menzel W; Keller G Dermatol Monatsschr; 1978 Apr; 164(4):302-3. PubMed ID: 668966 [No Abstract] [Full Text] [Related]
4. Histologic changes in the human skin melanoma after intratumorous treatment with BCG. Svejda J; Mechl Z; Sopková B; Foukal T Neoplasma; 1979; 26(2):215-21. PubMed ID: 471128 [TBL] [Abstract][Full Text] [Related]
5. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma]. Korting HC; Strasser S; Konz B Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889 [TBL] [Abstract][Full Text] [Related]
6. Pneumonitis with oral bcg. Schapira DV; McPherson TA N Engl J Med; 1977 Feb; 296(7):397. PubMed ID: 834203 [No Abstract] [Full Text] [Related]
7. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule. Gutterman JU; Mavligit G; McBride C; Frei E; Hersh EM Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319 [No Abstract] [Full Text] [Related]
8. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection. McKhann CF; Hendrickson CG; Spitler LE; Gunnarsson A; Banerjee D; Nelson WR Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms]. Grigorovich NA; Risina DIa; Nodel'son SE Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396 [TBL] [Abstract][Full Text] [Related]
10. [BCG-treatment of malignant melanoma]. Borberg H Internist (Berl); 1975 Oct; 16(10):482-5. PubMed ID: 1107254 [No Abstract] [Full Text] [Related]
11. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine. Caplan SE; Kauffman CL J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):783-5. PubMed ID: 8912582 [No Abstract] [Full Text] [Related]
12. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma. Dandapat MC; Mohapatra SK; Patra SK Indian J Cancer; 1985 Jun; 22(2):100-7. PubMed ID: 3842124 [No Abstract] [Full Text] [Related]
13. [Immunologic aspects of the treatment of melanoma]. Pawlowska EM Pol Tyg Lek; 1977 Jun; 32(24):939-41. PubMed ID: 882435 [No Abstract] [Full Text] [Related]
14. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases. Mastrangelo MJ; Bellet RE; Berkelhammer J; Clark WH Cancer; 1975 Oct; 36(4):1305-8. PubMed ID: 1175129 [TBL] [Abstract][Full Text] [Related]
15. [Effect of intra-tumoral injection of tuberculin-active protein on growth of transplantable mouse melanomas]. Saida T Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1389-98. PubMed ID: 6984864 [No Abstract] [Full Text] [Related]
16. Treatment of malignant melanoma by intratumoral injection of BCG. Pinsky CM; Hirshaut Y; Oettgen HF Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322 [No Abstract] [Full Text] [Related]
17. [Immuno- and chemoimmunotherapy and prevention of metastasis in skin melanoma]. Trapeznikov NN; Iavorskiĭ VV; Vagner RI; Gorodilova VV; Knysh IT Vestn Akad Med Nauk SSSR; 1978; (5):19-26. PubMed ID: 676458 [No Abstract] [Full Text] [Related]
18. Prospective comparison of intralesional and multipuncture BCG in recurrent intradermal melanoma. Nathanson L; Schoenfeld D; Regelson W; Colsky J; Mittelman A Cancer; 1979 May; 43(5):1630-5. PubMed ID: 376098 [TBL] [Abstract][Full Text] [Related]